ALTSCHULLER Susan
- SEC CIK
- 0001817988
No open-market purchases or sales filed in the past year.
Current role at each company
- CLYM Climb Bio, Inc.Chief Financial Officeras of Jan 8, 2026
- MURA Mural Oncology plcDirectoras of Aug 15, 2024
- CERE Cerevel Therapeutics Holdings, Inc.Chief Financial Officeras of Aug 5, 2024
- IMGN ImmunoGen, Inc.SVP AND CFOas of Dec 27, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists ALTSCHULLER Susan as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MURA Mural Oncology plc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 15, 2024 (view filing) | Aug 14 | 1 day | ALTSCHULLER SusanDirector | PPurchase | +10.0K | $3.21 | +$32.1K | New position10.0K after |
CERE Cerevel Therapeutics Holdings, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 (view filing) | Dec 20 | 1 day | ALTSCHULLER SusanChief Financial Officer | SSale | −13.8K | $41.42 | −$571.9K | −44.9%16.9K after |